Compagnie Lombard Odier SCmA - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 90 filers reported holding GALENA BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
Compagnie Lombard Odier SCmA ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q1 2016$3,0000.0%2,0000.0%0.00%
Q4 2015$3,0000.0%2,0000.0%0.00%
Q3 2015$3,0000.0%2,0000.0%0.00%
Q2 2015$3,0000.0%2,0000.0%0.00%
Q1 2015$3,0000.0%2,0000.0%0.00%
Q4 2014$3,000
-25.0%
2,0000.0%0.00%
Q3 2014$4,000
-33.3%
2,0000.0%0.00%
Q2 2014$6,000
+20.0%
2,0000.0%0.00%
Q1 2014$5,0002,0000.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q3 2014
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 375,000$855,0000.93%
HIGHLAND CAPITAL MANAGEMENT LP 800,000$1,824,0000.12%
Alyeska Investment Group, L.P. 780,000$1,778,0000.07%
KMS FINANCIAL SERVICES, INC 119,500$272,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 539,150$1,229,0000.04%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 25,100$57,0000.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 349,400$793,000,0000.02%
COMPTON CAPITAL MANAGEMENT INC /RI 12,000$27,0000.02%
Diversified Trust Co 40,000$91,0000.01%
PITTENGER & ANDERSON INC 18,000$41,0000.01%
View complete list of GALENA BIOPHARMA INC shareholders